MedTrace Logo

A New Device for Measuring of Lung Photoplethysmography and Pulmonic Arterial Saturation

NCT02894970 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 120

Last updated 2016-09-09

No results posted yet for this study

Summary

To evaluate feasibility of photoplethysmography (PPG) of pulmonary arteries in adults children and neonates and to compare normal controls to premature newborns suffering from patent ductus arteriosus and neonates suffering from pulmonary hypertension.

Conditions

  • Patent Ductus Arteriosus
  • Pulmonary Hypertension

Interventions

DEVICE

Pulmonary PPG

Five minutes check with a lights source with two wave lengths of infrared and a detector.

Sponsors & Collaborators

  • Israel Science Foundation

    collaborator OTHER

  • Shaare Zedek Medical Center

    lead OTHER

Eligibility

Min Age
1 Day
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-10-31
Primary Completion
2017-07-31
Completion
2017-07-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02894970 on ClinicalTrials.gov